Format

Send to

Choose Destination
Br J Cancer. 2018 Mar 20;118(6):857-866. doi: 10.1038/bjc.2017.477. Epub 2018 Jan 23.

Development and validation of a plasma-based melanoma biomarker suitable for clinical use.

Author information

1
Geneseq Biosciences Pty Ltd, PO Box 309, Balaclava, VIC 3183, Victoria, Australia.

Abstract

This corrects the article DOI: 10.1038/bjc.2017.85.

PMID:
29360813
PMCID:
PMC5886119
DOI:
10.1038/bjc.2017.477
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center